BridgeBio in United States
17 jobs at BridgeBio in United States
Professionals who showed interest in the company
-
Eric Delore
Technical Writer/Technical Publications Manager
Related companies
-
B M
-
-
-
B A I
-
B B C
-
B C
-
B H H P
-
-
-
B I
-
-
-
B I
-
B P
-
-
-
B H H C
-
B C
-
B P L
-
-
BridgeBio Palo Alto, United StatesBridgeBio · is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in a ...
-
Regional Sales Director
4 days ago
BridgeBio Minneapolis, United StatesAbout BridgeBio · BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in gene ...
-
Manager, Community
4 days ago
BridgeBio Raleigh, United StatesAbout QED Therapeutics & BridgeBio Pharma · QED Therapeutics, an affiliate of BridgeBio Pharma , focuses on developing targeted treatments for FGFR-driven skeletal dysplasias, particularly Achondroplasia. Achondroplasia is the most common form of genetically-driven short stature. ...
-
Field Reimbursement Manager
3 days ago
BridgeBio Palo Alto, United StatesBridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in acad ...
-
BridgeBio Palo Alto, United StatesEidos Therapeutics, an affiliate of BridgeBio Pharma, · is a Phase 3 developmental-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-defined family ...
-
BridgeBio San Francisco, United StatesCalcilytix Therapeutics , an affiliate of BridgeBio Pharma, is developing encaleret (CLTX-305), a negative allosteric modulator of the calcium-sensing receptor (CaSR) for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), a genetic cause of hypoparathyroidism. Encale ...
-
BridgeBio Palo Alto, United StatesAbout BridgeBio Gene Therapy & BridgeBio Pharma · BridgeBio Gene Therapy, a subsidiary of BridgeBio Pharma, is focused on discovering and developing drugs for patients with grievous genetic diseases. We do this by: · Finding the right starting points to target diseases at their ...
-
BridgeBio Palo Alto, United StatesEidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3 developmental-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-defined family of ...
-
BridgeBio San Francisco, United StatesCalcilytix Therapeutics, an affiliate of BridgeBio Pharma, is developing encaleret (CLTX-305), a negative allosteric modulator of the calcium-sensing receptor (CaSR) for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), a genetic cause of hypoparathyroidism. Encaler ...
-
BridgeBio San Francisco, United StatesBridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in acad ...
-
BridgeBio San Francisco, United StatesBridgeBio · is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in a ...
-
BridgeBio Palo Alto, United StatesBridgeBio · is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in a ...
-
BridgeBio San Francisco, United StatesBridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in acad ...
-
Field Reimbursement Manager
4 days ago
BridgeBio Orlando, United StatesBridgeBio · is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in a ...
-
BridgeBio San Francisco, United StatesBridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in acad ...
-
Regional Sales Director
3 days ago
BridgeBio Palo Alto, United StatesBridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in acad ...
-
BridgeBio San Francisco, United StatesCalcilytix Therapeutics , an affiliate of BridgeBio Pharma, is developing encaleret (CLTX-305), a negative allosteric modulator of the calcium-sensing receptor (CaSR) for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), a genetic cause of hypoparathyroidism. Encale ...